$0.28
+
$0.01 (3.70%)
End-of-day quote: 05/02/2024
ASX:EYE
Nova Eye Medical Annual Report
| Year | Year | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2009 | 2007 | 2005 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$13.38M | $16.14M | $79.43M | $71.81M | $73.02M | $62.76M | $54.38M | $43.08M | $58.31M | $44.42M | $26.96M | |
| GM % | Gross Margin % |
|
82.89% | 81.56% | 58.42% | 57.05% | 57.43% | 52.51% | 50.84% | 49.50% | 49.94% | 48.02% | 51.25% | |
| OM | Operating Margin |
|
-72.50% | -43.66% | -4.44% | -0.11% | 7.79% | 4.32% | 4.27% | 0.07% | 7.93% | 6.53% | 4.15% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.05 | $-0.04 | $-0.04 | $0.01 | $0.03 | $0.02 | $0.01 | $-0.01 | $0.04 | $0.06 | $-0.02 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | 0.00% | 0 | -0.00% | |
| Sha. | Shares |
|
145.58m | 143.6m | 143.6m | 121.15m | 114.15m | 107.65m | 107.65m | 84.91m | 84.91m | 68.4m | 61.24m | |
| OCF | Operating Cash Flow |
|
$-4.72M | $-4.21M | $0.52M | $-3.50M | $5.22M | $6.89M | $2.70M | $1.94M | $3.96M | $1.93M | $-0.78M | |
| FCF | Free Cash Flow |
|
$-6.72M | $-4.93M | $-2.12M | $-14.04M | $0.10M | $5.40M | $1.68M | $1.33M | $3.07M | $0.86M | $-1.29M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.07 | $-0.05 | $-0.04 | $-0.12 | $-0.03 | $0.03 | $-0.00 | $-0.01 | $0.01 | $-0.00 | $-0.06 |
